WO2008154350A3 - Utilisation d'agonistes de jonctions serrées pour supprimer des réponses immunes - Google Patents
Utilisation d'agonistes de jonctions serrées pour supprimer des réponses immunes Download PDFInfo
- Publication number
- WO2008154350A3 WO2008154350A3 PCT/US2008/066057 US2008066057W WO2008154350A3 WO 2008154350 A3 WO2008154350 A3 WO 2008154350A3 US 2008066057 W US2008066057 W US 2008066057W WO 2008154350 A3 WO2008154350 A3 WO 2008154350A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tight junction
- immune responses
- suppress immune
- agonists
- junction agonists
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 3
- 230000028993 immune response Effects 0.000 title abstract 3
- 210000001578 tight junction Anatomy 0.000 title abstract 3
- 102000000591 Tight Junction Proteins Human genes 0.000 title abstract 2
- 108010002321 Tight Junction Proteins Proteins 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 230000008236 biological pathway Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La présente invention concerne des susbtances et des procédés permettant de supprimer une réponse immune excessive ou non désirée. Selon certains modes de mise en oeuvre, des agonistes des voies biologiques responsables de l'ouverture et de la fermeture des jonctions serrées (par exemple, des agonistes de jonctions serrées) sont utilisés dans des compositions présentant des antigènes afin de supprimer une réponse immune contre l'antigène.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94297807P | 2007-06-08 | 2007-06-08 | |
US60/942,978 | 2007-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008154350A2 WO2008154350A2 (fr) | 2008-12-18 |
WO2008154350A3 true WO2008154350A3 (fr) | 2009-02-26 |
Family
ID=40130444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/066057 WO2008154350A2 (fr) | 2007-06-08 | 2008-06-06 | Utilisation d'agonistes de jonctions serrées pour supprimer des réponses immunes |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008154350A2 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338297A (en) * | 1980-02-19 | 1982-07-06 | Michael Jacob G | Polypeptide active pollen immunosuppressant fraction |
US20050119171A1 (en) * | 2001-08-10 | 2005-06-02 | Genset S.A. | Human cdnas and proteins and uses thereof |
US20060165722A1 (en) * | 2005-01-14 | 2006-07-27 | University Of Maryland, Baltimore | Peptides for delivery of mucosal vaccines |
US20060276399A1 (en) * | 1998-08-03 | 2006-12-07 | University Of Maryland - Baltimore | Peptide antagonists of zonulin and methods for use of the same |
US20070122423A1 (en) * | 2001-08-17 | 2007-05-31 | Glaxosmithkline Biologicals Sa | Derp1 and proderp1 allergen derivatives |
-
2008
- 2008-06-06 WO PCT/US2008/066057 patent/WO2008154350A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338297A (en) * | 1980-02-19 | 1982-07-06 | Michael Jacob G | Polypeptide active pollen immunosuppressant fraction |
US20060276399A1 (en) * | 1998-08-03 | 2006-12-07 | University Of Maryland - Baltimore | Peptide antagonists of zonulin and methods for use of the same |
US20050119171A1 (en) * | 2001-08-10 | 2005-06-02 | Genset S.A. | Human cdnas and proteins and uses thereof |
US20070122423A1 (en) * | 2001-08-17 | 2007-05-31 | Glaxosmithkline Biologicals Sa | Derp1 and proderp1 allergen derivatives |
US20060165722A1 (en) * | 2005-01-14 | 2006-07-27 | University Of Maryland, Baltimore | Peptides for delivery of mucosal vaccines |
Also Published As
Publication number | Publication date |
---|---|
WO2008154350A2 (fr) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007100908A3 (fr) | Vecteurs anédoviraux chimériques | |
LTPA2018010I1 (lt) | Žmogaus anti-IL-23 antikūnai, kompozicijos, metodai ir panaudojimai | |
WO2010011944A3 (fr) | Procédés de criblage de protéines | |
WO2006083936A3 (fr) | Anticorps anti-ephb2 et methodes d'utilisation associees | |
NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
WO2007084321A3 (fr) | Anticorps dirigés contre ox-2/cd200 et utilisations correspondantes | |
WO2017147542A3 (fr) | Conjugaison optimisée d'anticorps spécifique d'un site de transglutaminase | |
WO2011047087A3 (fr) | Détection de protéine par l'intermédiaire de nanorapporteurs | |
NO20084356L (no) | Anti TAT226-antistoffer og immunokonjugater | |
PH12019501796A1 (en) | Low ph pharmaceutical composition comprising t cell engaging antibody constructs | |
CU20120095A7 (es) | Antagonistas de pcsk9 | |
IL204542A (en) | Unique monoclonal antibodies for protofibrillary form of cellulose-amyloid protein, methods and uses thereof | |
WO2007133290A8 (fr) | Anticorps anti-ox40l et méthodes correspondantes | |
WO2006107924A3 (fr) | Procede permettant de differencier les animaux infectes par ehrlichia canis des animaux vaccines | |
BRPI0821211A2 (pt) | Anticorpo anti-humano cd34 humanizado, o método de preparação e usos do mesmo. | |
EP4219560A3 (fr) | Anticorps neutralisant l'intégrine alpha v bêta 8 | |
WO2009134429A3 (fr) | Procédés et compositions pour moduler une tolérance immunologique | |
NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
WO2009035738A3 (fr) | Utilisation d'une analyse elispot de cellules sécrétrices d'anticorps pour évaluer les réponses des anticorps suite à leur exposition à un antigène | |
WO2008043000A3 (fr) | Différenciation entre animaux vaccinés et animaux infectés (differentiate infected from vaccinated animals : diva) par ehrlicia canis | |
WO2009070507A3 (fr) | Antigènes d'anaplasma phagocytophilum (aph) et anticorps spécifiques des anaplasmes | |
WO2010056889A3 (fr) | Utilisation d'un anticorps et d'un cristal à base de terre rare | |
WO2010009856A3 (fr) | Protéine de liaison d’antigène goodpasture et sa détection | |
WO2006138324A3 (fr) | Antigenes de treponema pallidum pour l'elaboration de vaccin et essais diagnostiques | |
WO2008091643A3 (fr) | Système de culture in vitro pour évaluer la synergie du ciblage de voies immunosuppressives concomitantes à une immunothérapie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08770290 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08770290 Country of ref document: EP Kind code of ref document: A2 |